Physician profile
Nicholas E Boggs
NPI 1043523954
$504.97
in general payments reported to CMS, 2019-2025
9 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.26 · 2024: $185 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $104.27 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $97.83 | 2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $91.31 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $71.64 | 2024-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Exact Sciences Corporation | $57.08 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $38.99 | 2024-2025 | |
| Glaxosmithkline, LLC. | $14.84 | 2024 | Trelegy Ellipta |
| Inspire Medical Systems, INC. | $14.75 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Boggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.